 FREEHOLD, N.J., Oct. 14, 2021 GLOBE NEWSWIRE -- Avalon GloboCare Corp. NASDAQ: AVCO Avalon or The Company, a clinical-stage global developer of cell-based technologies and therapeutics, today announced it has successfully co-developed a novel platform of S-layer coated emulsome technology SLET for next-generation drug delivery and cellular immunotherapy, together with Professor Uwe Sleytr and the University of Natural Resources and Life Sciences BOKU in Vienna, Austria. 